# Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

> **NCT00457691** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 768 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** 5 fluorouracil
- **DRUG:** irinotecan
- **DRUG:** levo- leucovorin
- **DRUG:** sunitinib
- **DRUG:** 5 fluorouracil
- **DRUG:** irinotecan
- **DRUG:** levo- leucovorin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00457691
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 768 (ACTUAL)
- **Last updated:** 2015-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457691, "Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00457691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*